Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2012-11-19 Investor Presentation
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Investor Presentation 15 pages 1.8MB
Investor Presentation Classification · 95% confidence The document is an investor presentation released by Imugene on 20 November 2012. It contains detailed information about the company's commercialisation strategy for its Linguet drug delivery technology, including market opportunities, development plans, regulatory environment, and business models. The content is structured as a presentation with slides and graphics, focusing on financial highlights, strategic direction, and product development milestones. There is no indication that this is a formal financial report, earnings release, or regulatory filing. The document is not a brief announcement or a certification but a detailed presentation aimed at investors. Therefore, the most appropriate classification is Investor Presentation (IP).
2012-11-19 English
Initial Director's Interest Notice 2 pages 84.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held or contracts noted. This is a report of personal share transactions or interests by a company director. The document length is short and focused solely on director interests, matching the definition of Director's Dealing filings. Therefore, the appropriate classification is DIRS (Director's Dealing).
2012-11-05 English
CGP: Consegna Elects to return Aspen Medisys 2 pages 136.5KB
Regulatory Filings Classification · 90% confidence The document text is mostly unreadable or corrupted, containing mostly non-standard characters and no discernible content. There are no identifiable keywords, regulatory references, report titles, or fiscal period dates. The document length is 3818 characters, which is relatively short and does not contain any clear financial data or report content. Given the lack of meaningful content and the corrupted nature of the text, the best classification is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2012-10-31 English
Changes to the Board of Directors 2 pages 199.9KB
Board/Management Information Classification · 100% confidence The document announces changes to the company's Board of Directors, including the resignation of the CEO and appointment of a new non-executive director. It focuses on management and board composition updates rather than financial results, regulatory filings, or other report types. There is no indication of financial data, voting results, or other report content. Therefore, this document fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a straightforward announcement of board changes, not a report or presentation.
2012-10-30 English
Appendix 4C - quarterly 5 pages 139.2KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4C Quarterly report for entities admitted on the basis of commitments' and contains detailed quarterly financial data including consolidated cash flow statements, payments to directors, financing activities, and reconciliation of cash. The presence of quarterly period end dates (e.g., 30 September 2012) and detailed financial data confirms this is a quarterly financial report. The document length is 8976 characters, which is substantive and contains actual financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2012
2012-10-30 English
Final Director's Interest Notice 2 pages 100.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares held directly and indirectly, and notes the date the director ceased to be a director. The content focuses on personal shareholdings and interests of a company director rather than financial results, management changes, or other corporate filings. This matches the definition of 'Director's Dealing' filings, which report personal share transactions or holdings by company directors and executives. The document length is 2282 characters, which is consistent with a notice rather than a full report. Therefore, the appropriate classification is DIRS (Director's Dealing).
2012-10-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.